Let's check out the LLY charts amid FDA approval of the company's Alzheimer's drug.
Let's kick the tires and review the charts and indicators.
The technical signals for the maker of outdoor recreational equipment are bullish.
Shares of Everi could grind a little higher from here, but here's what investors should do now.
Here's where aggressive traders could go long.
Let's review the charts and indicators.
There isn't much technical history for the company that went public in the spring, but what is there is positive for this Jim Cramer fave.
MGA's charts show it could correct further in time and price.
Here's what Jim Cramer expects to hear from GSK at this week's investor meeting.
Aggressive traders could probe the long side of XPO.